Table 1.
Clinical parameters | Tissues with ABCB11+TLSs (34) | Tissues without ABCB11+TLSs (96) | Total (110) | P value |
---|---|---|---|---|
Age(year) | ||||
<56 | 10 (27.8%) | 26 (72.2%) | 36(100%) | 0.620 |
≥56 | 24 (32.4%) | 50 (67.6%) | 74(100%) | |
Gender | ||||
male | 33(35.9%) | 59(64.1%) | 92(100%) | 0.011* |
female | 1(5.6%) | 17(94.4%) | 18(100%) | |
Tobacco | ||||
active | 21(53.8%) | 18(46.2%) | 39(100%) | 0.000* |
unactive | 8(15.1%) | 45(84.9%) | 53(100%) | |
Alcohol | ||||
active | 24(63.2%) | 14(36.8%) | 38(100%) | 0.000* |
unactive | 2(5.7%) | 33(94.3%) | 35(100%) | |
Tumor size(cm) | ||||
≤2.5 | 12(18.5%) | 53(81.5%) | 65(100%) | 0.000* |
>2.5 | 21(51.2%) | 20(48.8%) | 41(100%) | |
Differentiation | ||||
good | 6(27.3%) | 16(72.7%) | 22(100%) | 0.033* |
moderate | 14(24.6%) | 43(75.4%) | 57(100%) | |
poor | 12(54.5%) | 10(45.5%) | 22(100%) | |
Lymphatic metastasis | ||||
yes | 18(48.6%) | 19(51.4%) | 37(100%) | 0.003* |
no | 13(20.6%) | 50(79.4%) | 63(100%) |